IMM 2.94% 33.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 601 Posts.
    lightbulb Created with Sketch. 839
    Must agree with your comment above regarding 'late breaking abstract' - as data cut-off was 14th May?
    There is still an embargo on SITC abstracts until 11th November and therefore there will be additional data/info that has not yet been released.
    'Ladenburg Thalman' latest note today:-
    https://hotcopper.com.au/data/attachments/3777/3777107-6839dc1523cc15afbcdb9e3596066a0c.jpg

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
-0.010(2.94%)
Mkt cap ! $480.0M
Open High Low Value Volume
33.0¢ 33.5¢ 32.0¢ $1.703M 5.215M

Buyers (Bids)

No. Vol. Price($)
1 211685 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 279000 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.